AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ropee 0.75% Injection

Prescription Icon
Prescription Required

Marketer

Aesmira Lifesciences Pvt Ltd

Salt Composition

Ropivacaine (0.75%)

Overview Ropee 0.75% Injection

Roxa-ject 0.75% Injection provides localized anesthesia for minor surgical interventions, including dental, oral, diagnostic, and other therapeutic procedures. Administration should be performed solely by qualified medical personnel. This medication temporarily blocks nerve impulses to the brain, producing localized numbness for a comfortable procedure. Common, generally mild and transient, adverse reactions may include low blood pressure, nausea, vomiting, bradycardia, pyrexia, anemia, paresthesia, cephalalgia, pruritus, and backache. Persistent numbness or any concerning side effects at the injection site warrant immediate medical attention. Prior to administration, patients with pre-existing cardiac conditions or those using antiarrhythmics should inform their physician. Pregnant or breastfeeding individuals should seek medical guidance before use. Due to potential dizziness, operating machinery or driving is strongly discouraged while under the influence of this medication.

Uses of Ropee 0.75% Injection

Regional numbing achieved through localized anesthetic.

Major Benefits of Ropee 0.75% Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Ropee 0.75% Injection:

  • Hypotension (low blood pressure)
  • Nausea
  • Vomiting
  • Slow heart rate
  • Fever
  • Anemia (low number of red blood cells)
  • Paresthesia (tingling or pricking sensation)
  • Headache
  • Itching
  • Back pain

How to use Ropee 0.75% Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Ropee 0.75% Injection works:

Ropee 0.75% Injection provides localized pain relief by interrupting nerve impulses to the brain, thereby reducing pain perception.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Ropee 0.75% Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable formulation of Ropee, at a concentration of 0.75%, is typically regarded as safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Ropee 0.75% Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible harm to the infant.

DrivingDrivingUNSAFE

Administering Ropee 0.75% Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.

KidneyKidneySAFE IF PRESCRIBED

The use of Ropee 0.75% Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate that dose modification for Ropee 0.75% Injection might be unnecessary in such cases. However, medical advice is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Ropee 0.75% Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Ropee 0.75% Injection :

NA

Facts to Know About Ropee 0.75% Injection

LabelValue
Type of Compound Substituted amide
Addictive None.
Medication Classification Pain relievers
Mechanism of Action Regional numbing agents (amide-type)

FAQs on Ropee 0.75% Injection

A 0.75% Ropee injection provides localized anesthesia prior to surgical or diagnostic interventions. This solution facilitates regional insensibility, mitigating pain during the introduction of medical devices like needles and catheters.
Ropivacaine 0.75% Injection is provided as a solution for epidural injection or intravenous infusion. The duration of its effects varies with the administration route and dosage, typically lasting three to ten hours. Consult your physician for any questions concerning this medication's effects.
Ropee 0.75% Injection, a levobupivacaine formulation, exhibits reduced cardiotoxicity and neurotoxicity compared to bupivacaine. Consequently, it offers a superior safety profile.
Injection of Ropee 0.75% may commonly cause tingling or pins-and-needles sensations, backache, an irregular heartbeat, lightheadedness, cephalgia, elevated blood pressure, urinary retention, fever, chills, and nausea. These adverse reactions typically resolve after the medication's effects diminish. Nevertheless, should these side effects intensify or cause concern, seek medical advice.
The human nervous system exhibits heightened susceptibility to local anesthetic agents compared to other bodily systems. Consequently, initial manifestations of local anesthetic toxicity include auditory disturbances (ringing in the ears), visual impairment, vertigo, altered sensation of the tongue, and numbness surrounding the mouth.
Ropee 0.75% Injection is a non-steroidal, long-acting amide local anesthetic. Its mechanism of action involves the interruption of nerve impulses at the injection site, producing temporary numbness and pain relief in the treated area.
Ropee 0.75% Injection
89
MRP 108
17% off